Croda International (LON:CRDA) Reaches New 52-Week Low – Here’s Why

Croda International Plc (LON:CRDA) shares hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 2,880 ($37.21) and last traded at GBX 2,893 ($37.38), with a volume of 332606 shares changing hands. The stock had previously closed at GBX 2,889 ($37.33).

Croda International Stock Performance

The company has a market cap of £4.04 billion, a price-to-earnings ratio of 24.86, a P/E/G ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72. The company has a fifty day moving average of GBX 3,195.43 and a two-hundred day moving average of GBX 3,509.76.

Croda International (LON:CRDA) last announced its quarterly earnings results on Tuesday, February 25th. The company reported GBX 142.60 ($1.84) EPS for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. Equities research analysts anticipate that Croda International Plc will post 181.8307268 EPS for the current year.

Croda International Increases Dividend

The firm also recently declared a dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Thursday, April 10th will be given a GBX 63 ($0.81) dividend. This is a boost from Croda International’s previous dividend of $47.00. This represents a yield of 2.03%. The ex-dividend date is Thursday, April 10th. Croda International’s dividend payout ratio is 93.66%.

Insider Activity

In related news, insider Ian Bull purchased 400 shares of the firm’s stock in a transaction dated Tuesday, February 25th. The stock was bought at an average price of GBX 3,240 ($41.87) per share, with a total value of £12,960 ($16,746.35). Over the last 90 days, insiders acquired 415 shares of company stock valued at $1,343,845. Insiders own 0.93% of the company’s stock.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.